Similar companies
| Company | Stocktwits Subscribers | |
|---|---|---|
 |
AmgenAMGN |
14,300 0% |
 |
Gilead SciencesGILD |
77,173 0% |
 |
Catalyst PharmaceuticalsCPRX |
15,706 0% |
 |
Inovio PharmaceuticalsINO |
93,165 0% |
 |
Anavex Life SciencesAVXL |
22,277 0.1% |
Month over Month
Subscribing Stocktwits Users
| Dec 2024 | 75,579 | |
| Nov 2024 | 75,741 | |
| Oct 2024 | 75,835 | |
| Sep 2024 | 75,863 |
How many users are following Vaxart on StockTwits?
The interest in Vaxart on StockTwits is decent, with a following of 75,876 investors.
Analyzing Stocktwits Subscribers, how is Vaxart performing compared to its industry peers?
Compared to its peers, Vaxart ranks in the 49th percentile when it comes to Stocktwits Subscribers.
What has been the change in Vaxart's StockTwits followers over the past month?
The number of followers for Vaxart on StockTwits has risen by 0.3% in the last month, indicating a growing interest or optimism among investors. For investors, this upward trend in follower count is an important indicator to consider, as it may reflect broader market sentiments and could have implications for Vaxart's price performance.
What is StockTwits?
StockTwits is a social media platform designed specifically for the investing community. It enables investors and traders to share market insights, strategies, and real-time news updates. Essentially, it's a specialized network for financial market discussions, often characterized by brief, tweet-like posts.
Why is it important for Vaxart investors to monitor its StockTwits followers?
For investors in Vaxart, tracking the number of followers on StockTwits can be highly beneficial. The platform's follower count offers a direct gauge of investor interest and sentiment surrounding Ford. An increasing follower count typically suggests growing investor attention and can be an indicator of rising market enthusiasm or concern about the company's prospects. This data can provide investors with valuable insights into market trends, potential shifts in investor behavior, and broader perceptions of Ford in the investment community.
Sign up and get more insights on Vaxart.
